In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice

Circulation

Volumn 104, Issue 2, 2001, Pages 197-202

  Laurat, E ^a   Poirier, B ^a   Tupin, E ^a   Caligiuri, G ^b   Hansson, G K ^c   Bariety J ^a   Nicoletti, A ^a  

^a HÔPITAL BROUSSAIS   (France)

^b BICHAT HOSPITAL   (France)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Atherosclerosis; Inflammation; Inhibitors; Interleukins; Lymphocytes

Indexed keywords

APOLIPOPROTEIN E; GAMMA INTERFERON; INTERLEUKIN 10; PENTOXIFYLLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; IMMUNE RESPONSE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL;

EID: 0035838424     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.104.2.197     Document Type: Article

References (32)

1. Functionality of specific immunity in atherosclerosis
2. Two types of murine helper T cell clone, I: Definition according to profiles of lymphokine activities and secreted proteins
3. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis
4. The role of interleukin 12 in the development of atherosclerosis in apoE-deficient mice
5. Detection of activated T lymphocytes in the human atherosclerotic plaque
6. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice
7. A tale of two diseases: Atherosclerosis and rheumatoid arthritis
8. Clinical investigation of the effects of pentoxifylline in patients with severe peripheral occlusive vascular disease
9. Ticlopidine-pentoxifylline combination in the treatment of atherosclerosis and the prevention of cerebrovascular accidents
10. Regulatory effects of pentoxifylline on T-helper cell-derived cytokine production in human blood cells
11. Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1- but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats
12. Effects of pentoxifylline and nabumetone on the serum levels of IL-1beta and TNFalpha in rats with adjuvant arthritis
13. Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice
14. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations
15. Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1
16. IFN-γ potentiates atherosclerosis in apoE knockout mice
17. Interleukin-10 blocks atherosclerotic events in vitro and in vivo
18. Protective role of interleukin-10 in atherosclerosis
19. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production
20. Peripheral vascular stenosis in apolipoprotein E-deficient mice: Potential roles of lipid deposition, medial atrophy, and adventitial inflammation
21. Inhibition of human interleukin-12 production by pentoxifylline
22. Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-alpha and interleukin-1 beta by human mononuclear cells
23. Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: An effect of the novel anti-inflammatory drug lisofylline
24. Increasing cAMP attenuates activation of mitogen-activated protein kinase
25. Pentoxifylline: A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy
26. The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice
27. The combined role of P- and E-selectins in atherosclerosis
28. Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo
29. Differentiation of effector phenotypes of CD4+ and CD8+ T cells
30. Effect of lisofylline and pentoxifylline on the bacterial-stimulated production of TNF-alpha, IL-1 beta and IL-10 by human leucocytes
31. Immunomodulatory effect of pentoxifylline during human allograft rejection: Involvement of tumor necrosis factor-alpha and adhesion molecules
32. Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis